A61P 13 - Drugs for disorders of the urinary system

Patents for A61P 13 - Drugs for disorders of the urinary system (56,135)
12/2006
12/06/2006	EP1368319B1 Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use as adenosine receptor-selective ligands
12/06/2006	EP1318977B1 Substituted phenylcyclohexane carboxylic acid amides and the use thereof
12/06/2006	EP1291343B1 Hydroxyformamidine derivatives and medicines containing the same
12/06/2006	EP1210086B1 Use of halofuginone for treating urethral stricture
12/06/2006	EP0983346B1 Short peptides which selectively modulate the activity of serine/threonine kinases
12/06/2006	EP0948334B1 Method of treating prostatic diseases using active vitamin d analogues
12/06/2006	CN1874766A Use of neurokinin antagonists in the treatment of urinary incontinence
12/06/2006	CN1872857A Reverse-turn mimetics and method relating thereto
12/06/2006	CN1872856A Reverse-turn mimetics and method relating thereto
12/06/2006	CN1872302A Compound Chinese herbal medicine of fossil, and preparation method
12/06/2006	CN1872300A Composition for treating calculi in urinary system and preparation method
12/06/2006	CN1872247A Medication of medicinal broth for treating disease of turbid urine in type of accumulation of damp-heat in the body, and preparation method
12/06/2006	CN1872246A Capsule of Baji, and preparation method
12/06/2006	CN1872223A Medication of medicinal broth for treating nephritis in type of insufficiency of kidney-yang, and preparation method
12/06/2006	CN1872208A Enema of Chinese traditional medicine for treating chronic prostatitis in type of kidney-derficiency
12/06/2006	CN1872207A Enema of Chinese traditional medicine for treating chronic prostatitis in type of congestion
12/06/2006	CN1872163A Drop pills of medicine for treating benign hyperplasia of prostate, and preparation method
12/06/2006	CN1872107A Chinese and Western compound preparations of alpha receptor blocking pharmacon, preparation method, and application
12/06/2006	CN1872064A Drop pills of piperazine ferulic acid, and preparation method
12/06/2006	CN1872062A Fibrauretine, and preparation method
12/06/2006	CN1872055A Compound preparation of amoxicillin and ambroxol hydrochloride suitable to use for children, prescription and preparation method
12/06/2006	CN1288243C PEG-modified uricase
12/06/2006	CN1288156C Nianzhou Strain and its use
12/06/2006	CN1288153C Use of 2-amino-4-pyridylmethyl-thiazoline derivatives as inhibitors of inducible NO-synthase
12/06/2006	CN1288150C Pharmaceutically active sulfonamide derivatives bearing both lipophilic and ionisable moieties as inhibitors of protein junkinases
12/06/2006	CN1288148C 1,2,3,4-tetrahydroisoquinolines derivatives as urotensin II receptor antagonists
12/06/2006	CN1288137C 7-heterocyclyl quinoline and thieno[2,3,-b] pyridine derivatives useful as antagonists of gonadotropin releasing hormone
12/06/2006	CN1287848C Kidney failure resistant formula and its preparation process
12/06/2006	CN1287847C Chinese medicine for treating acute and chronic nephritis and uremia
12/06/2006	CN1287826C Medication for treating chronic prostatitis and preparation method
12/06/2006	CN1287812C Medicine for treating chronic nephritis and its preparing process
12/06/2006	CN1287801C Medicine composition for treating prostatitis
12/06/2006	CN1287781C Use of KCNQ potassium excitant in preparation of medicine with the functions of inducing or maintaining bladder performances
12/05/2006	USRE39419 Estrogen agonist/antagonist metabolites
12/05/2006	US7145009 Pirazino(aza)indole derivatives
12/05/2006	US7144918 Enzyme inhibitors; anticancer agents
12/05/2006	US7144912 drugs such as (4-methoxy-5-(1H-indol-2yl-methylene)-2,2'-bi-1H-pyrrole) used as anticarcinogenic or antitumor agents
12/05/2006	US7144892 Treatment of cardiovascular and related pathologies
12/05/2006	US7144879 Substituted metal-phthalocyanines, their preparation and the use thereof
12/05/2006	CA2396458C Pyrimidine carboxamides useful as inhibitors of pde4 isozymes
11/2006
11/30/2006	WO2006126625A1 Pharmaceutical comprising pyrazolone derivative
11/30/2006	WO2006126514A1 Arylacetate derivative having isoxazole skeleton
11/30/2006	WO2006126505A1 Stat function inhibitor and application thereof
11/30/2006	WO2006125554A1 Use of cyanopyrimidines for the treatment of cardiovascular diseases
11/30/2006	WO2005105147A3 Combination of prostaglandin e2 receptor antagonists and renin-angiotensin system inhibitors for treating renal diseases
11/30/2006	US20060270839 Crystallization of IGF-1
11/30/2006	US20060270832 Novel x-conotoxin peptides (-II)
11/30/2006	US20060270738 Novel derivatives of 3,3-diphenylpropylamines
11/30/2006	US20060270718 e.g. N-(4-{1-Hydroxy-1-[1-(2-methoxyethyl)-1H-pyrrol-2-yl]-ethyl}-phenyl)-N-methyl-benzenesulfonamide; liver X receptor (LXR) agonist; antidiabetic, antiproliferative agent; lipid, metabolic disorders, obesity, diabetes, hypercholesterolemia, atherosclerosis, hyperlipoproteinemia
11/30/2006	US20060270693 Ether derivative
11/30/2006	US20060270681 Pyridazine derivatives
11/30/2006	US20060270679 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
11/30/2006	US20060270665 Combination comprising an agent decreasing VEGF activity and an agent decreasing EGF activity
11/30/2006	US20060270660 Processes for preparing substituted pyrimidines
11/30/2006	DE202006014919U1 Composition, useful for promoting bladder health and stabilizing immunosystems, comprises an extract Vaccinium macrocarpon, L-ascorbic acid, zinc and selenium
11/29/2006	EP1726590A1 Cycloalkanopyridine derivative
11/29/2006	EP1726584A1 2-aminoquinazoline derivative
11/29/2006	EP1725552A1 New quaternized quinuclidine esters
11/29/2006	EP1725540A1 Diaminopyrimidines as p2x3 and p2x2/3 antagonists
11/29/2006	EP1725247A1 Polyphenols as an intravesical agent for the prevention of transitional cell tumor implantation
11/29/2006	EP1725226A2 The treatment of inflammatory disorders and pain using beta-aminoalcohols
11/29/2006	EP1248804B1 Recombinant antibodies to human interleukin-1 beta
11/29/2006	CN1871347A Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in
11/29/2006	CN1871224A 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof
11/29/2006	CN1871029A Drug containing chymase inhibitor as the active ingredient
11/29/2006	CN1871018A Pharmaceutical formulation comprising lanthanum compounds
11/29/2006	CN1869208A Preparation of caterpillar fungus SOD and health-care product containing caterpillar fungus SOD
11/29/2006	CN1868519A Formula for Liuwei Dihuang with vitamin prepns., prepn. method and application therefor
11/29/2006	CN1868518A Shen-nao capsule for treating nephrosis and cardiovascular and cerebrovascular disease and its prepn. method
11/29/2006	CN1868487A Use of stub-like bacillus prepn. or acellular stub-like bacillus prepn.
11/29/2006	CN1868476A Application of Nepider in preparing medicine to accelerate ejection of calculus for urinary system
11/29/2006	CN1868458A Controlled release composition and method of producing the same
11/29/2006	CN1286844C Medicinal composition containing angiotensin II receptor antagonist and vitamin B
11/29/2006	CN1286835C Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/29/2006	CN1286821C 2-anilino-pyrimidine derivatives as cyclin dependent kinase inhibitors
11/28/2006	US7141599 Immunosuppressive effects of administration of a cyclooxygenase-2 inhibitor, a leukotriene B4 receptor inhibitor and a cyclosporin
11/28/2006	US7141580 activity as prostaglandin E2 receptor antagonists
11/28/2006	US7141558 2-ethyl and 2-ethylidene-19-nor-vitamin D compounds
11/28/2006	US7141547 Albumin fusion proteins comprising GLP-1 polypeptides
11/28/2006	US7141363 Purposeful movement of human migratory cells away from an agent source
11/28/2006	CA2379640C Certain alkylene diamine-substituted heterocycles
11/28/2006	CA2026915C Stem cell factor
11/23/2006	WO2006124753A2 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	WO2006123618A1 Oxidative stress inhibitor
11/23/2006	WO2006123517A1 Crystal polymorph of hydroxynorephedrin derivative hydrochloride
11/23/2006	WO2006071538A3 Substituted biaryl analogues
11/23/2006	US20060264479 Nicotinamide Derivatives Useful as p38 Inhibitors
11/23/2006	US20060264436 Method of Treating a Psychotic Disorder
11/23/2006	US20060264434 Chemokine receptor binding heterocyclic compounds
11/23/2006	US20060264432 Adenosine A1, A2a, and A2b receptor ligands; coupling the 2-mercapto-3,5-dicyano-4-aryl-6-aminopyridine to a substituted alkyl or alkenyl compound; antiischemic agents; cardiovascular disorders
11/23/2006	US20060264397 Compositions and methods for targeting cancer cells
11/23/2006	US20060263457 Pharmaceutical composition for treatment of emiction disorders caused by benign prostate hyperplasia (BPH) and the method
11/23/2006	US20060263455 Composition for preventing urinary system infections
11/23/2006	US20060263422 Pharmaceutical composition containing decoy and use of the same
11/23/2006	CA2608447A1 Oxidative stress inhibitor
11/23/2006	CA2607472A1 Antipyretic agents against vr1-antagonist-induced increases in body temperature
11/23/2006	CA2605337A1 Crystal polymorph of hydroxynorephedrin derivative hydrochloride
11/22/2006	EP1724278A1 Nitrogenous fused-ring derivatives, medicinal compositions containing the derivatives, and use thereof as drugs
11/22/2006	EP1724270A2 Phenylacetamido-thiazole derivatives, process for their preparation and their use as antitumor agents
11/22/2006	EP1724267A1 Pyrimidine derivative

1 ... 216 217 218 219 220 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 ... 562